What are the management options for pre-eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pre-eclampsia

The management of pre-eclampsia requires urgent hospitalization for assessment, close maternal and fetal monitoring, blood pressure control, seizure prophylaxis, and timely delivery based on disease severity and gestational age. 1

Diagnosis and Initial Assessment

  • Pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) after 20 weeks of gestation with proteinuria or evidence of end-organ damage 1, 2
  • All women with pre-eclampsia should be hospitalized initially to confirm diagnosis, assess severity, and monitor progression 1, 3
  • Maternal monitoring should include:
    • Blood pressure measurements every 4 hours (more frequently if severe) 1
    • Clinical assessment including evaluation for clonus and neurological symptoms 1
    • At least twice weekly blood tests for hemoglobin, platelet count, liver enzymes, and renal function including uric acid 1, 4
    • Repeated assessment for proteinuria if not already present 1

Blood Pressure Management

  • Severe hypertension (>160/110 mmHg) requires urgent treatment in a monitored setting using: 1

    • Oral nifedipine (10 mg, repeat every 20 minutes to maximum 30 mg) 1
    • IV labetalol (20 mg bolus, then 40 mg if needed after 10 minutes, followed by 80 mg every 10 minutes to maximum 220 mg) 1
    • IV hydralazine (5 mg bolus, then 10 mg every 20-30 minutes to maximum 25 mg) 1
  • For non-severe hypertension (≥140/90 mmHg), treat with oral antihypertensives aiming for target diastolic BP of 85 mmHg and systolic BP between 110-140 mmHg 1

    • First-line agents include methyldopa, labetalol, oxprenolol, and nifedipine 1
    • Reduce or cease antihypertensives if diastolic BP falls below 80 mmHg 1

Seizure Prevention with Magnesium Sulfate

  • Magnesium sulfate should be administered for convulsion prophylaxis in women with: 1

    • Pre-eclampsia with severe hypertension 1
    • Hypertension with neurological signs or symptoms 1, 4
  • Magnesium sulfate dosing for pre-eclampsia/eclampsia: 5

    • Initial dose: 4-5g IV over 15-20 minutes 5
    • Maintenance: 1-2g/hour continuous IV infusion 5
    • Continue for 24 hours postpartum 1, 4
    • Monitor for magnesium toxicity by checking deep tendon reflexes, respiratory rate, and urine output 5

Fluid Management

  • Limit total fluid intake to 60-80 mL/hour to avoid pulmonary edema 1, 4
  • Aim for euvolemia; avoid "running dry" as this increases risk of acute kidney injury 1
  • Avoid NSAIDs for postpartum analgesia, especially with renal dysfunction 1

Fetal Monitoring

  • Initial assessment should confirm fetal well-being 1
  • Serial ultrasound surveillance including fetal biometry, amniotic fluid assessment, and umbilical artery Doppler 1, 4
  • More frequent monitoring if fetal growth restriction is present 4

Timing of Delivery

  • Delivery is the definitive treatment for pre-eclampsia 2, 3

  • Deliver at 37 weeks' gestation or earlier if any of the following develop: 1

    • Repeated episodes of severe hypertension despite treatment with 3 classes of antihypertensives 1
    • Progressive thrombocytopenia 1
    • Progressively abnormal renal or liver enzyme tests 1
    • Pulmonary edema 1
    • Abnormal neurological features (severe headache, visual scotomata, convulsions) 1
    • Non-reassuring fetal status 1
  • For severe pre-eclampsia between 24-34 weeks:

    • Consider expectant management in selected cases to improve neonatal outcomes 3
    • Administer antenatal corticosteroids for fetal lung maturity 2, 3

Postpartum Management

  • Continue close monitoring for at least 3 days postpartum as eclampsia can still develop 1
  • Monitor BP at least every 4 hours while awake 1
  • Continue antihypertensives and taper slowly after days 3-6 postpartum 1
  • Avoid abrupt cessation of antihypertensive therapy 1
  • Review at 3 months postpartum to ensure BP, urinalysis, and laboratory abnormalities have normalized 1

Prevention Strategies for High-Risk Women

  • Low-dose aspirin (75-162 mg/day) before 16 weeks' gestation (definitely before 20 weeks) for women with strong clinical risk factors: 1

    • Prior pre-eclampsia
    • Chronic hypertension
    • Pre-gestational diabetes
    • BMI >30 kg/m²
    • Antiphospholipid syndrome
    • Assisted reproduction
  • Supplemental calcium (1.2-2.5 g/day) if intake is likely low (<600 mg/day) 1

Special Considerations

  • Home BP monitoring is useful for managing chronic hypertension in pregnancy 1
  • Avoid low molecular weight heparin for pre-eclampsia prevention 1
  • Women with pre-eclampsia should be counseled about increased lifetime cardiovascular risk 1
  • Regular exercise during pregnancy may help reduce the likelihood of hypertension 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Preeclampsia: an update.

Acta anaesthesiologica Belgica, 2014

Research

Management of severe preeclampsia.

Acta clinica Belgica, 2010

Guideline

Management of Pre-eclampsia Complicated by Hypokalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.